Tirzepatide

Tirzepatide is a dual incretin receptor agonist used as a research tool to study metabolic signaling networks involving GIP and GLP-1 pathways.

• Research class: Dual GIP/GLP-1 receptor agonist peptide

• Primary research purpose: Investigating incretin-mediated control of glucose homeostasis and endocrine-metabolic signaling

• Common research endpoints: Insulin/glucagon pathway dynamics, nutrient-handling signals, gastric-emptying physiology, appetite-regulation biology, and energy-balance markers

• Model context: Frequently used in controlled metabolic research systems to evaluate multi-pathway incretin effects

60mg COA provided by Johnny Blaze